Recent Finacing
Recent Raise
Homology Medicines develops in vivo gene therapies for rare genetic diseases using AMEnDR, a nuclease-free AAV‑mediated homologous recombination platform for precise genomic correction and therapeutic sequence insertion.
Focus Areas
Recent Investors
Valuation as of 01/12/2021
Total Raised
Funding rounds
Investors
See the team members at Homology Medicines.
